Improving the specificity of recombinant immunoassays for Lyme disease [1]

Journal of Clinical Microbiology

Volumn 41, Issue 6, 2003, Pages 2791-

  Porwancher, Richard ^a  

^a ST FRANCIS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ANTIGEN;

ANTIBODY RESPONSE; BORRELIA BURGDORFERI; HUMAN; IMMUNOASSAY; LETTER; LYME DISEASE; NONHUMAN; PRIORITY JOURNAL; RECOMBINANT DNA TECHNOLOGY; SENSITIVITY AND SPECIFICITY;

BORRELIA; BORRELIA BURGDORFERI;

EID: 0037504188     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.6.2791.2003     Document Type: Letter

References (4)

1. Biggerstaff, B. 2000. Comparing diagnostic tests: a simple graphic using likelihood ratios. Stat. Med. 19:649-663.
2. Gomes-Solecki, M. J., G. P. Wormser, M. Schriefer, G. Neuman, L. Hannafey, J. D. Glass, and R. J. Dattwyler. 2002. Recombinant assay for serodiagnosis of Lyme disease regardless of OspA vaccination status. J. Clin. Microbiol. 40:193-197.
3. Hefty, P. S., C. S. Brooks, A. M. Jett, G. L. White, S. K. Wikel, R. C. Kennedy, and D. R. Akins. 2002. OspE-related, OspF-related, and Elp lipoproteins are immunogenic in baboons infected with Borrelia burgdorferi and in human Lyme disease patients. J. Clin. Microbiol. 40:4256-4265.
4. Porwancher, R. 1999. A reanalysis of IgM western blot criteria for the diagnosis of early Lyme disease. J. Infect. Dis. 179:1021-1024.